Corvus Pharma CEO Richard Miller fields follow-up questions about last week's atopic dermatitis data for the ITK inhibitor soquelitinib
BiotechTV - News
00:00
Intro
Brad introduces the show, Ellucent, and welcomes Richard Miller to discuss Corvus and soquelitinib data.
Play episode from 00:00
Transcript
